4-Chloro-α-[3-(trifluoromethyl)phenoxy]benzeneacetic acid 2-(acetylamino)ethyl ester
CAS: 24136-23-0
Ref. 3D-FC101484
1mg | Discontinued | ||
2mg | Discontinued | ||
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued |
Product Information
- Arhalofenate
- Aceticacid, (p-chlorophenyl)[(a,a,a-trifluoro-m-tolyl)oxy]-, ester withN-(2-hydroxyethyl)acetamide, (-)- (8CI)
- Acetamide, N-(2-hydroxyethyl)-,(p-chlorophenyl)[(a,a,a-trifluoro-m-tolyl)oxy]acetate (ester), (-)- (8CI)
- (-)-2-Acetamidoethyl 4-chlorophenyl(3-trifluoromethylphenoxy)acetate
- Jnj 39659100
- Mbx 102
4-Chloro-alpha-[3-(trifluoromethyl)phenoxy]benzeneacetic acid 2-(acetylamino)ethyl ester is a drug that belongs to the class of P-glycoprotein (Pgp) substrates. It has been shown to have good pharmacokinetics, as well as good pharmacological properties in animal studies. 4-Chloro-alpha-[3-(trifluoromethyl)phenoxy]benzeneacetic acid 2-(acetylamino)ethyl ester is not metabolized by the liver and can be used for the treatment of metabolic disorders such as hyperlipidemia. This drug also has a protective effect on the liver cells from oxidative damage.